9/7/2021MSD's KEYTRUDA Approved in China in Combo with Chemotherapy for First-...

9/7/2021GlobalData: China Leads Biosimilar Development and Marketing in APAC

9/7/2021Move over, Shanghai and Beijing? Suzhou wants to be the 'Pharmacy Vall...

9/6/2021NHSA Unveils the Draft Interim Regulations for Medical Insurance Inspe...

9/3/2021NHC Issues the Working Procedures for Adjustment of the List of Drugs ...

9/3/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...

9/3/2021Wyeth Secured Win With Punitive Damages But Courts Had Different Opini...

9/3/2021Investment Prospects in China's Biopharmaceuticals and Biomaterials In...

9/3/2021Healthcare Sector Could Be the Next Target of Chinese Regulatory Crack...

9/1/2021CDE Seeks Comments on Implementation Advice on ICH Guidelines E18, M3(...

9/1/2021Junshi Bio and Coherus Completes Rolling BLA Submission of Toripalimab...

9/1/2021CStone Files Chinese NDA of Sugemalimab for Stage III NSCLC

9/1/2021Harbour BioMed Gets Chinese IND Approval for PII Trial of Anti-FcRn Ba...

8/31/2021NHSA Issues the Notice on the Public Service Item List of Centralized ...

8/31/2021Financial-related Company News in Brief (August 2021)

8/31/2021Eight Central Government Agencies Issues the Pilot Plan for Deepening ...

8/31/2021Jingxin In-licenses Epilepsy Drug from Bio-Pharm Solutions for $40M

8/30/2021NMPA Issues the Notice on Deepening Certification and Licensing Separa...

8/30/2021Ligand's Partner Gloria Bio Wins Chinese Approval for Zimberelimab

8/30/2021Winners and Losers in China's Sweeping Private-Sector Crackdown

8/29/2021NHSA Concludes the List of Drugs Passing Form Evaluation for Inclusion...

8/27/2021Junshi Bio Granted Chinese IND Approval for Subcutaneous Injection of ...

8/27/2021CDE Issues Three Guidance Documents on Non-clinical Research of Nanome...

8/27/2021Recent Executive Moves

8/27/2021Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...

8/25/2021IQVIA: Chinese Hospital Drug Market Rose 14.2% in MAT Q2/2021

8/25/2021Alphamab and CSPC Enter Licensing Deal on Anti-HER2 bsAntibody KN026 i...

8/24/2021Review of Top Ten Overseas Out-licensing Deals of Domestic Phama Compa...

8/24/2021IQVIA: Overall Chinese Pharma Market Growth down 7.9% in 2020

8/23/2021BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...

Page:97/371 Total number of articles:11111: [First][<<] [95] [96] [97] [98] [99] [>>] [End]